###begin article-title 0
###xml 4 9 4 9 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GLUT9</italic>
The GLUT9 Gene Is Associated with Serum Uric Acid Levels in Sardinia and Chianti Cohorts
###end article-title 0
###begin p 1
###xml 333 338 333 338 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GLUT9</italic>
###xml 473 474 473 474 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 486 489 486 489 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;16</sup>
###xml 517 518 517 518 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 530 533 530 533 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;16</sup>
###xml 546 549 546 549 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;11</sup>
###xml 821 826 821 826 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GLUT9</italic>
High serum uric acid levels elevate pro-inflammatory-state gout crystal arthropathy and place individuals at high risk for cardiovascular morbidity and mortality. Genome-wide scans in the genetically isolated Sardinian population identified variants associated with serum uric acid levels as a quantitative trait. They mapped within GLUT9, a Chromosome 4 glucose transporter gene predominantly expressed in liver and kidney. SNP rs6855911 showed the strongest association (p = 1.84 x 10-16), along with eight others (p = 7.75 x 10-16 to 6.05 x 10-11). Individuals homozygous for the rare allele of rs6855911 (minor allele frequency = 0.26) had 0.6 mg/dl less uric acid than those homozygous for the common allele; the results were replicated in an unrelated cohort from Tuscany. Our results suggest that polymorphisms in GLUT9 could affect glucose metabolism and uric acid synthesis and/or renal reabsorption, influencing serum uric acid levels over a wide range of values.
###end p 1
###begin title 2
Author Summary
###end title 2
###begin title 3

###end title 3
###begin p 4
###xml 328 333 328 333 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GLUT9</italic>
###xml 496 501 496 501 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GLUT9</italic>
###xml 855 860 855 860 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GLUT9</italic>
High serum uric acid levels lead to gout and increase the risk of cardiovascular and kidney disease. To determine what genetic factors might contribute to uric acid levels, we conducted genome-wide scans of single nucleotide variations in DNA in population samples from Sardinia and Chianti. We report here that variants in the GLUT9 gene are associated with altered uric acid levels in both populations. Unexpectedly, rather than being directly involved in uric acid synthesis or secretion, the GLUT9 gene encodes a glucose transporter. It is of interest that the gene is predominantly expressed in liver, a major site of uric acid synthesis, and in kidney, where uric acid is excreted and reabsorbed. However, it now remains to be determined how altered glucose uptake can indirectly affect synthesis or excretion/reabsorption of uric acid, and whether GLUT9 may provide a target for the therapeutic modification of uric acid levels.
###end p 4
###begin title 5
Introduction
###end title 5
###begin p 6
###xml 165 166 165 166 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen-0030194-b001">1</xref>
###xml 277 278 277 278 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen-0030194-b002">2</xref>
###xml 279 280 279 280 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen-0030194-b003">3</xref>
###xml 504 512 <span type="species:ncbi:9606">patients</span>
Serum uric acid (UA) levels are frequently elevated in conjunction with several disorders, including obesity, hyperlipidemia, atherosclerosis, and hyperinsulinemia [1]. Most widely discussed have been findings of high serum UA in individuals at risk of cardiovascular disease [2,3]. High UA levels are causal in gout crystal arthropathy, and according to some authors, are associated with a negative cardiovascular risk profile. Elevated UA is a risk factor for all-cause and cardiovascular mortality in patients with prevalent cardiovascular disease, and an important prognostic factor in hypertension.
###end p 6
###begin p 7
###xml 173 174 173 174 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen-0030194-b004">4</xref>
###xml 175 176 175 176 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen-0030194-b005">5</xref>
###xml 285 291 <span type="species:ncbi:9606">humans</span>
Identifying factors that affect UA levels could help our understanding of their role in pathology, improve clinical decisions about whether to treat moderate hyperuricemia [4,5], and help identify new targets for intervention aimed at managing undesirably high UA levels. UA levels in humans are generally higher than in other species because the gene for the primary enzyme that transforms UA in other species, uricase, is inactivated. Consequently, UA levels are determined by the balance between the production of UA through purine catabolism (the two important contributors being dietary purine levels and purines released from the DNA and RNA of damaged cells) and the rate of excretion/reabsorption in the kidney and intestine.
###end p 7
###begin p 8
###xml 378 379 378 379 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen-0030194-b006">6</xref>
###xml 590 591 590 591 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen-0030194-b007">7</xref>
###xml 741 742 741 742 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen-0030194-b008">8</xref>
Several metabolic defects that may increase serum UA levels have been described. Changes in the level of UA synthesis can result from mutations or variation in activity of enzymes involved in purine metabolism. In one relevant instance, a microRNA has been reported that seems to modulate the synthesis of UA through its repression of phosphoribosyl pyrophosphate synthetase 1 [6]. Tissue ischemia can also stimulate UA production by the upregulation of xanthine oxidase. The alternative route to increased UA levels is a decline in UA clearance in the kidney. The urate/anion transporter [7] is highly expressed in the proximal kidney tubule, and genetic variants in the genes that code for the transporter may contribute to hyperuricemia [8].
###end p 8
###begin p 9
###xml 262 267 262 267 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GLUT9</italic>
In an attempt to discriminate genetic factors affecting UA levels, we scanned the genome with a panel of 362,129 single nucleotide polymorphisms (SNPs) in 4,305 Sardinian individuals. Here, we report association between SNPs found in a glucose transporter gene, GLUT9, and UA levels. We also show the association is confirmed in an independent population.
###end p 9
###begin title 10
Results
###end title 10
###begin p 11
###xml 85 106 85 106 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="sec" rid="s4">Materials and Methods</xref>
###xml 149 151 149 151 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;7</sup>
###xml 344 349 344 349 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GLUT9</italic>
###xml 351 352 351 352 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen-0030194-b009">9</xref>
###xml 371 379 371 379 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pgen-0030194-g001">Figure 1</xref>
###xml 381 389 381 389 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pgen-0030194-st001">Table S1</xref>
###xml 515 516 515 516 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen-0030194-b009">9</xref>
###xml 655 662 655 662 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pgen-0030194-t001">Table 1</xref>
###xml 665 673 665 673 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pgen-0030194-g002">Figure 2</xref>
###xml 943 951 943 951 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pgen-0030194-g003">Figure 3</xref>
###xml 636 641 <span type="species:ncbi:9606">women</span>
###xml 650 653 <span type="species:ncbi:9606">men</span>
UA levels and genotypes were assessed for a cohort of individuals from Sardinia (see Materials and Methods). Using a Bonferroni threshold of 1.3 x 10-7 (0.05/362,129), we selected 38 SNPs potentially associated with UA levels. Unexpectedly, rather than identifying variants in purine catabolism or in the urate transporter, the scan pointed to GLUT9 [9] on Chromosome 4 (Figure 1; Table S1). All SNPs exceeding the Bonferroni significance threshold map to the region that encodes this Class II glucose transporter [9]. The rare allele "G" of the top ranked SNP rs6855911 has an effect size of -0.317 mg/dl, with a more marked effect in women than in men (Table 1). Figure 2 shows the contributions of the two alleles of the SNP in homozygotes and heterozygotes. Their effect is observed across the full range of UA values. The strongest observed association of SNP rs6855911 and distribution of the SNPs in linkage disequilibrium are shown in Figure 3, along with the comparative linkage disequilibrium patterns in the HapMap Utah residents with ancestry from northern and western Europe (CEU) and Yoruba in Ibadan, Nigeria (YRI) samples.
###end p 11
###begin title 12
Genome-Wide Association Scan Results for UA Levels in Sardinian Cohort
###end title 12
###begin p 13
###xml 43 45 43 45 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">10</sub>
###xml 207 208 207 208 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 244 249 244 249 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GLUT9</italic>
###xml 254 258 254 258 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PJA2</italic>
Probability of association (plotted as -log10) according to their positions along the p to q arms of each chromosome (1 to 22 and X) for each of 362,169 SNPs that passed quality control filters. The highest p-values are at the positions of the GLUT9 and PJA2 genes, and are indicated by vertical dotted lines.
###end p 13
###begin p 14
###xml 28 33 28 33 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GLUT9</italic>
Effect Sizes of Two SNPs in GLUT9 on UA Levels in Sardinian and InCHIANTI Cohorts
###end p 14
###begin title 15
Boxplot for UA Levels Correlated with rs6855911 Genotypes in Sardinian and InCHIANTI Population Cohorts
###end title 15
###begin p 16
Standard boxplots are drawn with min, 0.25 quantile; median, 0.75 quantile; and 0.75 quantile + 1.5*IQR for the levels of UA (mg/dl). To increase readability, outliers were removed from the boxplots, but they were taken into account when estimating the parameters. Sample size for each genotype class is also annotated.
###end p 16
###begin title 17
###xml 82 87 82 87 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GLUT9</italic>
Association Results and Linkage Disequilibrium Patterns in Region Surrounding the GLUT9 Gene
###end title 17
###begin p 18
(A) Summary of the association between SNPs in the region and UA levels. The SNP showing strongest association (rs6855911) is highlighted. Other SNPs are colored according to their degree of disequilibrium with rs6855911, ranging from high (red), to intermediate (green), to low (blue). Transcripts in the region are indicated at the bottom of the graph, with an arrow indicating the direction of transcription.
###end p 18
###begin p 19
###xml 117 119 117 119 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen-0030194-b025">25</xref>
###xml 128 129 128 129 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">r</italic>
###xml 129 130 129 130 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 167 169 167 169 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen-0030194-b026">26</xref>
(B) Patterns of linkage disequilibrium in the region in Sardinia and in two of the HapMap populations (CEU and YRI) [25], where r2 values are calculated according to [26] and colored as (A). The grey bar marks the region of association and facilitates comparisons between the panels.
###end p 19
###begin p 20
###xml 174 178 174 178 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">WDR1</italic>
###xml 300 307 300 307 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pgen-0030194-t002">Table 2</xref>
In a sequential analysis in which we selected the best SNP for each trait and then conditioned on it to successively select the next best SNP, a marker in the adjacent gene, WDR1, was selected at the second round, meaning that its signal is-at least in part-statistically independent from rs6855911 (Table 2). These results can support either the presence of multiple variants in the same region or reflect different degrees of linkage disequilibrium with a causal SNP that remains to be identified.
###end p 20
###begin p 21
Association Signals Identified in a Sequential Analysis
###end p 21
###begin p 22
###xml 100 101 100 101 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 128 130 128 130 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;7</sup>
###xml 135 139 135 139 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PJA2</italic>
###xml 182 184 182 184 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen-0030194-b010">10</xref>
###xml 210 218 210 218 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pgen-0030194-g001">Figure 1</xref>
The only other gene showing a cluster of SNPs associated with UA levels-though at far less striking p-values (on the order of 10-7)-is PJA2, a ubiquitin ligase gene on Chromosome 5 [10]; its position marked in Figure 1. This possible association has not been examined further.
###end p 22
###begin p 23
###xml 277 282 277 282 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GLUT9</italic>
###xml 558 560 558 560 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen-0030194-b011">11</xref>
###xml 561 563 561 563 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen-0030194-b012">12</xref>
###xml 810 817 810 817 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pgen-0030194-t001">Table 1</xref>
###xml 822 830 822 830 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pgen-0030194-g002">Figure 2</xref>
###xml 993 994 993 994 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 1006 1009 1006 1009 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;11</sup>
###xml 1101 1102 1101 1102 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 1114 1117 1114 1117 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;12</sup>
###xml 1127 1132 1127 1132 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GLUT9</italic>
###xml 1248 1256 1248 1256 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pgen-0030194-g002">Figure 2</xref>
###xml 1532 1533 1532 1533 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 332 344 <span type="species:ncbi:9606">participants</span>
###xml 736 739 <span type="species:ncbi:9606">men</span>
###xml 747 752 <span type="species:ncbi:9606">women</span>
###xml 1302 1314 <span type="species:ncbi:9606">participants</span>
###xml 1352 1355 <span type="species:ncbi:9606">men</span>
###xml 1374 1379 <span type="species:ncbi:9606">women</span>
###xml 1406 1418 <span type="species:ncbi:9606">participants</span>
Based on the genetic results, we hypothesized that variants underlying the association with UA levels affect a critical step in UA production or elimination. We started to test this hypothesis by studying the relationship between UA and the two top strongly associated SNPs in GLUT9 in an independent population sample. We examined participants in the InCHIANTI study, an epidemiological study ongoing in two Italian towns in Chianti, Tuscany. A detailed description of the study design and data collection methods of the InCHIANTI study has been published [11,12]. The study population consists of 1,301 individuals (579 males and 722 females), comprising a random sample of the population aged 65 years and older supplemented with 30 men and 30 women randomly selected in each decade between ages 20 and 70. Table 1 and Figure 2 show that the results in this cohort replicate the findings in the Sardinian group. For SNP rs6855911, the allele G has a negative additive effect of 0.39 mg/dl (p = 1.54 x 10-11). Similarly, the rare allele G for rs7442295 has a negative additive effect of 0.42 mg/dl (p = 2.57 x 10-12). Again, GLUT9 variants significantly and comparably affect UA levels over the whole distribution of values, without a threshold (Figure 2). Interestingly, while none of the Sardinian participants had hyperuricemia (UA > 7.5 mg/dl in men and >6.2 mg/dl in women), in the InCHIANTI study, participants with at least one G allele had a significantly lower prevalence of hyperuricemia (AA: 11.1%; AG: 7.2%; GG: 3.5%; p = 0.009).
###end p 23
###begin p 24
###xml 46 48 46 48 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen-0030194-b013">13</xref>
###xml 177 185 177 185 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pgen-0030194-g002">Figure 2</xref>
###xml 297 302 297 302 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GLUT9</italic>
###xml 346 354 346 354 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pgen-0030194-g002">Figure 2</xref>
###xml 356 363 356 363 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pgen-0030194-t001">Table 1</xref>
UA levels generally increase with age (e.g., [13]), and the InCHIANTI cohort is considerably older than the Sardinian sample, resulting in higher mean values for each genotype (Figure 2). However, the values for corresponding age groups in the two are very similar, as are the contribution of the GLUT9 alleles and the greater effect in females (Figure 2; Table 1).
###end p 24
###begin p 25
###xml 99 101 99 101 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen-0030194-b013">13</xref>
###xml 395 397 395 397 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen-0030194-b014">14</xref>
###xml 466 471 466 471 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GLUT9</italic>
Because the Sardinian population, as a founder population, is relatively homogeneous (reviewed in [13]), it can facilitate the detection of associated SNPs but might emphasize genes that are important only on the island. In this respect, mainland Italian residents are both genetically much more heterogeneous and distinct from Sardinians (as distant from Sardinians as American Caucasians are [14]). Thus, the replication of allele effects in Chianti suggests that GLUT9 is involved in a general mechanism of UA production/elimination that may be biologically important in other populations as well.
###end p 25
###begin p 26
###xml 431 439 431 439 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pgen-0030194-st002">Table S2</xref>
###xml 668 676 668 676 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pgen-0030194-st003">Table S3</xref>
###xml 855 856 855 856 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">r</italic>
###xml 856 857 856 857 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 887 888 887 888 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">r</italic>
###xml 888 889 888 889 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 1110 1111 1110 1111 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 1208 1209 1208 1209 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
The initial SNPs tested and found associated with UA levels all fall in noncoding regions. To assess any candidate SNPs in the coding region and/or promoter of the gene, the exons and a 1.5 kb presumptive promoter region upstream of the transcription start site were amplified by PCR and sequenced in 30 individuals (ten for each homozygote and ten heterozygotes for rs6855911). The primers used to amplify the genes are listed in Table S2. The sequencing found no new SNPs. However, we identified several SNPs in Sardinian DNA samples that were previously described in other populations. They include six SNPs in the promoter region and nine in exons (results are in Table S3). Among the other SNPs in the region, rs16890979, a nonsynonymous SNP in exon 8 that produces a Val253Ile amino acid change, was in strong linkage disequilibrium with rs6855911 (r2 = 0.74 in the HapMap CEU and r2 = 1.0 among the 30 resequenced individuals). However, genotyping of that coding SNP in a further 541 Sardinians suggests that rs6855911 and other noncoding SNPs in the region are more strongly associated with UA levels (p < 0.0004 for rs737267 and other noncoding SNPs in strong linkage disequilibrium with rs6855911, p = 0.02 for rs16890979). Further analyses are necessary to identify the causal variant(s) in the region.
###end p 26
###begin title 27
Discussion
###end title 27
###begin p 28
###xml 22 27 22 27 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GLUT9</italic>
###xml 114 116 114 116 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen-0030194-b015">15</xref>
###xml 188 190 188 190 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen-0030194-b015">15</xref>
###xml 488 493 488 493 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GLUT9</italic>
###xml 403 406 <span type="species:ncbi:9606">Man</span>
How might variants of GLUT9 differentially affect UA levels? Studies have verified that GLUT9 transports glucose [15], and both characterized isoforms, comprising 540 and 511 amino acids [15], respectively, are highly expressed in liver and distal kidney tubules. In the liver, where much UA is synthesized, rare deficiency of glucose-6-phosphatase (Glycogenosis Type I; Online Mendelian Inheritance in Man 232200) leads to increased levels of UA. Variations in the uptake of glucose via GLUT9 might also result in increases or decreases in glucose-6-phosphate and modulate metabolism through the pentose phosphate shunt. Augmented levels of phosphoribosyl pyrophosphate synthesis, for example, could then lead to increased hepatic production of UA.
###end p 28
###begin p 29
###xml 45 50 45 50 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GLUT9</italic>
###xml 196 201 196 201 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GLUT9</italic>
###xml 301 303 301 303 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen-0030194-b016">16</xref>
###xml 482 487 482 487 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GLUT9</italic>
###xml 653 658 653 658 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">URAT1</italic>
###xml 702 703 702 703 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen-0030194-b007">7</xref>
###xml 837 842 837 842 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GLUT9</italic>
###xml 1159 1161 1159 1161 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen-0030194-b017">17</xref>
###xml 1190 1191 1190 1191 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen-0030194-b002">2</xref>
Alternatively, or in addition, the effect of GLUT9 on UA level may be exerted through effects on renal excretion. In the kidney, urate transport occurs in the proximal tubular epithelium, whereas GLUT9 is expressed in more distal nephron segments, perhaps the distal convoluted or connecting tubules [16]. However, those segments are relatively anaerobic, and one can speculate that the levels of lactate and other anions could be altered by metabolism from the glucose supplied by GLUT9, with consequent changes in organic anion concentration in the interstitium and neighboring proximal tubule cells. Anions are exchanged for urate by the transporter URAT1, with lactate as a preferred exchange ion [7], affecting the coupled process whereby filtered urate is reabsorbed from the urine in exchange for cytosolic organic anions. Hence, GLUT9 variants in the kidney could change the ambient level of organic anions and thereby alter urate reabsorption and circulating urate levels. Effects could be more marked in individuals with purine-rich diets, or in hypertensive individuals in whom reabsorption is favored by reduced blood flow in the proximal tubule [17] and/or localized ischemia [2].
###end p 29
###begin p 30
###xml 36 41 36 41 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GLUT9</italic>
###xml 277 279 277 279 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen-0030194-b018">18</xref>
Regardless of underlying mechanism, GLUT9 variants clearly have a significant modulating effect on levels of UA. Homozygotes for the two allelic variants differ in serum UA by 0.6 mg/dl, or on the order of 10% of the mean levels. Based on the findings in an independent study [18], such a difference in UA levels would change the rate of cardiovascular events by about 1%.
###end p 30
###begin p 31
###xml 85 87 85 87 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen-0030194-b019">19</xref>
###xml 104 105 104 105 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen-0030194-b004">4</xref>
###xml 611 619 611 619 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pgen-0030194-st004">Table S4</xref>
###xml 238 243 <span type="species:ncbi:9606">human</span>
In further assessing the impact of such variation, it is notable that many authors ([19] and review in [4]) have pointed out that UA can function as an antioxidant, and that at earlier times in evolution, this may have been beneficial to human populations, in fact leading to the inactivation of uricase. Consistent with a possible need for UA in past generations, we found that the observed allele associated with higher levels of UA, AA, is more common on a population level. Allele GG, which is associated with lower levels, occurs in only 6.9% of the Sardinian and 6.6 % of the InCHIANTI population sample (Table S4 gives the absolute numbers).
###end p 31
###begin p 32
###xml 379 380 379 380 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen-0030194-b003">3</xref>
###xml 756 761 756 761 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GLUT9</italic>
###xml 949 954 949 954 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GLUT9</italic>
###xml 488 500 <span type="species:ncbi:9606">participants</span>
###xml 611 614 <span type="species:ncbi:9606">men</span>
###xml 633 638 <span type="species:ncbi:9606">women</span>
###xml 892 900 <span type="species:ncbi:9606">patients</span>
In those individuals with intermediate levels of UA, it remains unclear whether it functions simply as an antioxidant that tends to increase in conditions characterized by tissue damage or whether it has a deleterious effect; and at very high levels UA is patently pathological. However, in individuals with very high levels, UA is patently pathological and mortality increases [3]. In such individuals, the G allele may be partially protective, and intriguingly, in the InCHIANTI study, participants with at least one G allele had a significantly lower prevalence of hyperuricemia (defined as UA >7.5 mg/dl in men and >6.2 mg/dl in women) compared to those with only A alleles. It would be of interest to verify whether variants of associated SNPs in the GLUT9 gene are less represented in particular groups of individuals with different clinical forms of hyperuricemia and in sporadic gout patients. Such effects would support the suggestion that GLUT9 may eventually provide a target for clinical intervention.
###end p 32
###begin title 33
Materials and Methods
###end title 33
###begin title 34
Recruitment and UA determinations.
###end title 34
###begin p 35
###xml 130 132 130 132 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen-0030194-b013">13</xref>
###xml 189 201 <span type="species:ncbi:9606">participants</span>
###xml 799 802 <span type="species:ncbi:9606">men</span>
###xml 835 840 <span type="species:ncbi:9606">women</span>
We recruited and phenotyped 6,148 individuals, male and female, 14-102 y old, from a cluster of four towns in the Lanusei Valley [13]. Blood samples were collected in the morning after the participants had been fasting for at least 12 h and after sitting for 15 min, both for SardiNIA and InCHIANTI cohorts. Aliquots of serum were immediately obtained and stored at -80 degreesC, and were subsequently used for the assessment of UA. UA (mg/dl) was measured using enzymatic-colorimetric methods (Bayer for SardiNIA; Roche Diagnostics for INCHIANTI). The lower limits of detection were 0.2 mg/dl, range 0.2-25.0 mg/dl, intra-assay and inter-assay coefficients of variation were equal to 0.5% and 1.7%, respectively. Hyperuricemia was defined as a serum urate concentration >7.5 mg/dl (450 mumol/l) in men and >6.2 mg/dL (372 mumol/l) in women, in agreement with clinical laboratory standards.
###end p 35
###begin title 36
Genotyping.
###end title 36
###begin p 37
###xml 499 501 499 501 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen-0030194-b020">20</xref>
In the Sardinian cohort, 3,329 and 1,412 individuals were genotyped with the Affymetrix 10K and Affymetrix 500K Mapping array set, respectively, with 436 individuals generating an overlapping dataset. We took advantage of the relatedness among individuals in our sample to reduce study costs. Using a modified Lander-Green algorithm, full genotypes on the 2,893 individuals typed with only the 10K panel were imputed based on stretches of shared haplotype, permitting analyses on 4,305 individuals [20].
###end p 37
###begin p 38
For genotyping for replication in the InCHIANTI cohort, allelic discrimination assays with predeveloped assay reagents (Applied Biosystems) for SNPs rs6855911 and rs7442295 were carried out using an ABI 7900HT sequencer detector system. Each 10 mul reaction volume was prepared according to manufacturer's directions, and contained 5 mul of twice-concentrated TaqMan Universal PCR master mix, 0.25 mul of 40-fold concentrated SNP genotyping assay mix with amplifying primers and oligonucleotide labeled with VIC or FAM reporter dyes for the corresponding alleles, 1 mul containing 5 ng of template DNA from an InCHIANTI subject, and 3.75 mul of water. Assays were run in 96-well format. Controls included DNA with sequence-verified homozygous alleles, DNA with heterozygous alleles, or no template DNA, in each assay plate. Following allele discrimination assays, a total of 14 random samples representing each allelic state were also checked by direct sequencing, confirming allele calls in all cases.
###end p 38
###begin title 39
Statistical analyses.
###end title 39
###begin p 40
###xml 56 58 56 58 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen-0030194-b020">20</xref>
###xml 450 451 450 451 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
Analyses in the Sardinia cohort were carried out as in [20]. We focused on 362,129 SNPs that passed quality control checks. We used a linear regression model to estimate the association between each SNP and UA levels. To avoid inflated type I error rates due to the departure from normality of measured UA levels, we applied an inverse normal transformation to the phenotype prior to analysis. We used an additive model and included sex, age, and age2 as covariates.
###end p 40
###begin p 41
###xml 446 448 446 448 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen-0030194-b021">21</xref>
###xml 968 970 968 970 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen-0030194-b021">21</xref>
###xml 1177 1179 1177 1179 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen-0030194-b013">13</xref>
###xml 1180 1182 1180 1182 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen-0030194-b021">21</xref>
###xml 1302 1304 1302 1304 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen-0030194-b013">13</xref>
###xml 1305 1307 1305 1307 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen-0030194-b021">21</xref>
For individuals who had genotype data available at the SNP being tested, we coded genotypes as 0, 1, or 2, depending on the number of copies of an arbitrary reference allele for each SNP. For individuals with missing genotype data, we used the Lander-Green algorithm to estimate the number of copies of the allele carried by each individual (based on the genotypes of family members) and assigned each individual a score ranging between 0 and 2 [21]. This estimate incorporates allele frequency information, the genotypes of relatives for the SNP of interest, and flanking marker data. For computational efficiency, the Lander-Green algorithm was applied to sub-pedigrees, each including no more than 20-25 individuals, resulting in a dataset where the average analysis unit consisted of a family with 12.3 members and 3.2 generations. Finally, we used a variance component approach to account for correlation between different observed phenotypes within each family [21]. To evaluate association on the X chromosome, we modeled a polygenic variance component shared according to an X-linked kinship coefficient in addition to the usual autosomal polygenic variance component [13,21]. Further, we assumed that average phenotypic values for hemizygous males would be the same as for homozygous females [13,21].
###end p 41
###begin p 42
###xml 178 179 178 179 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
Analysis for replication in the InCHIANTI population was carried out by again coding genotypes as 0, 1, or 2 and fitting a linear regression model adjusting for sex, age, and age2.
###end p 42
###begin p 43
###xml 513 514 513 514 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
For the sequential analysis, the best SNP for each trait was selected first, and the analysis was conditioned on it to select successively the next best SNP. To carry out this conditioning, we simply added the best SNP as a covariate to the model and repeated the genome-wide association scan for all other SNPs. The same process was repeated in successive rounds. This sequential analysis can help identify regions with multiple independent association signals. After five rounds, additional SNPs identified had p-values that were far less significant.
###end p 43
###begin title 44
Sequencing of exons and putative promoter regions with SNP variants.
###end title 44
###begin p 45
###xml 123 128 123 128 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GLUT9</italic>
###xml 261 263 261 263 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen-0030194-b022">22</xref>
###xml 310 312 310 312 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen-0030194-b023">23</xref>
###xml 427 429 427 429 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen-0030194-b024">24</xref>
###xml 540 548 540 548 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pgen-0030194-st002">Table S2</xref>
Oligonucleotide primers to amplify putative promoter regions and exons, including the splice sites for two isoforms of the GLUT9 gene, were designed based on the exon-intron borders represented in the University of California Santa Cruz (UCSC) genome assembly [22] using the primer prediction program Primer3 [23] interfaced with the UCSC genome browser. In the putative promoter regions, repeats were masked by Repeat Masker [24], and only primers outside the repeats were selected. A list of primers used to amplify the exons is given in Table S2.
###end p 45
###begin p 46
###xml 149 150 147 148 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
The exons were amplified by PCR in 25 mul reactions containing 0.2 mM dNTPs, final concentration 1 muM each of forward and reverse primers, 2 mM MgCl2, and 50 ng of genomic DNA as template, with 1 unit recombinant Taq DNA polymerase (Invitrogen). The cycling conditions were as follows: 95 degreesC 5 min, followed by 95 degreesC for 30 sec, 60 degreesC for 30 sec, and 72 degreesC for 30 sec for 30 cycles. The PCR products were purified by using ExoSAP-IT (USB Corporation) and were sequenced bidirectionally using the ABI PRISM BigDye Terminator v3.1 Cycle Sequencing Kit according to the manufacturer's recommendations, on an ABI PRISM 3100 Sequencer, and visualized with DNA Genetic Analyzer software (ABI PRISM 3100 Genetic Analyzer).
###end p 46
###begin title 47
Supporting Information
###end title 47
###begin title 48
###xml 22 23 22 23 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 33 35 33 35 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;6</sup>
SNPs with Genome-Wide p-Value <10-6 for an Effect on UA Level in the Sardinian Cohort
###end title 48
###begin p 49
###xml 41 46 41 46 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GLUT9</italic>
###xml 103 105 103 105 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen-0030194-b022">22</xref>
The 40 SNPs all fall in or very near the GLUT9 gene; positions of the sequences are according to UCSC [22], March 2006 genome build.
###end p 49
###begin p 50
(62 KB DOC)
###end p 50
###begin p 51
Click here for additional data file.
###end p 51
###begin title 52
###xml 66 71 66 71 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GLUT9</italic>
Primers Used to Amplify Each Exon and Putative Promoter Region of GLUT9
###end title 52
###begin p 53
###xml 95 100 95 100 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GLUT9</italic>
###xml 160 162 160 162 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen-0030194-b022">22</xref>
Forward and reverse primers are listed for exons and a 1.5 kb putative promoter regions of the GLUT9 isoform 2. Positions along the gene are according to UCSC [22] March 2006 genome build. Dashes indicate exons with no polymorphic SNPs in the database.
###end p 53
###begin p 54
(30 KB DOC)
###end p 54
###begin p 55
Click here for additional data file.
###end p 55
###begin title 56
###xml 21 26 21 26 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GLUT9</italic>
Sequence Variants in GLUT9 Putative Promoter, Exons, and Introns in Sardinian Individuals with Alternative Genotypes for SNP rs6855911
###end title 56
###begin p 57
###xml 212 220 212 220 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pgen-0030194-st001">Table S1</xref>
###xml 334 339 334 339 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GLUT9</italic>
###xml 347 349 347 349 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen-0030194-b025">25</xref>
###xml 567 575 567 575 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pgen-0030194-st001">Table S1</xref>
###xml 779 784 779 784 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GLUT9</italic>
DNA segments from ten individuals homozygous for the minor allele (GG), the major allele (AA), or heterozygous (AG) for rs6855911 were amplified by PCR and sequenced. For each individual, using primers listed in Table S1, sequence was determined for 1.5 kb putative promoter region for isoform 2, exons, and intron/exon boundaries of GLUT9. SNPs [25] with the indicated identification numbers were found in the samples, and genotypes are shown for each. An asterisk marks the strongest candidate for association. SNPs in putative promoter regions and exons are as in Table S1. SNP rs3733589 in exon 4 was monomorphic in the samples tested (unpublished data). Amino acid positions in the protein refer to protein accession number NP001001290. The Gly 25 Arg change is specific to GLUT9 isoform I (NP064425). nd, allelic calls not determined
###end p 57
###begin p 58
(67 KB DOC)
###end p 58
###begin p 59
Click here for additional data file.
###end p 59
###begin title 60
Numbers of Individuals with Each Genotype for Two SNPs in Sardinia and InCHIANTI Population Cohorts
###end title 60
###begin p 61
(26 KB DOC)
###end p 61
###begin p 62
Click here for additional data file.
###end p 62
###begin title 63
Accession Numbers
###end title 63
###begin p 64
###xml 89 92 <span type="species:ncbi:9606">Man</span>
The National Center for Biotechnology Information (NCBI) Online Mendelian Inheritance in Man (OMIM, ) accession number for Glycogen storage disease Ia, simulating primary gout and xanthomatosis, is MIM 232200.
###end p 64
###begin p 65
The NCBI Entrez database () accession number for Solute carrier family 2, member 9 protein isoform I, is NP 064425.
###end p 65
###begin p 66
We thank Michael Sutters for expert advice on the formulation of the possible action of GLUT9 in kidney to affect UA levels.
###end p 66
###begin p 67
###xml 399 402 <span type="species:ncbi:9606">men</span>
###xml 411 416 <span type="species:ncbi:9606">women</span>
###xml 609 621 <span type="species:ncbi:9606">participants</span>
###xml 723 735 <span type="species:ncbi:9606">participants</span>
We warmly express gratitude to Monsignore Piseddu, Bishop of Ogliastra; the mayors of Lanusei, Ilbono, Arzana, and Elini; the head of the local Public Health Unit ASL4; the residents of the towns; and the ProgeNIA physicians and staff for their help and cooperation. Of the 1,530 subjects originally sampled for INCHIANTI, 94% agreed to participate. For the present study, we analyzed data from 570 men and 705 women who consented to providing DNA samples for analysis and had data on UA serum level. The study protocol was approved by the INRCA Ethical Committee. The SardiNIA study was carried out on 6,148 participants. The study, including the protocols for subject recruitment and assessment, the informed consent for participants (and assent forms for those 14-18), and the overall analysis plan was reviewed and approved by IRB boards for the Istituto di Neurogenetica e Neurofarmacologia (INN; Cagliari, Italy), the MedStar Research Institute (responsible for intramural research at the National Institutes of Aging, Baltimore, Maryland); and the University of Michigan (Ann Arbor, Michigan).
###end p 67
###begin title 68
Abbreviations
###end title 68
###begin p 69
Utah residents with ancestry from northern and western Europe
###end p 69
###begin p 70
glucose transporter 9
###end p 70
###begin p 71
uric acid
###end p 71
###begin p 72
Yoruba in Ibadan, Nigeria
###end p 72
###begin title 73
References
###end title 73
###begin article-title 74
Uric acid: A new look at an old risk marker for cardiovascular disease, metabolic syndrome, and type 2 diabetes mellitus: The urate redox shuttle
###end article-title 74
###begin article-title 75
Uric acid as a cardiovascular risk factor in arterial hypertension
###end article-title 75
###begin article-title 76
Hyperuricemia in primary and renal hypertension
###end article-title 76
###begin article-title 77
Is there a pathogenetic role for uric acid in hypertension and cardiovascular and renal disease?
###end article-title 77
###begin article-title 78
Essential hypertension, progressive renal disease, and uric acid: a pathogenetic link?
###end article-title 78
###begin article-title 79
Redirection of silencing targets by adenosine-to-inosine editing of miRNAs
###end article-title 79
###begin article-title 80
Molecular identification of a renal urate anion exchanger that regulates blood urate levels
###end article-title 80
###begin article-title 81
Association between intronic SNP in urate-anion exchanger gene, SLC22A12, and serum uric acid levels in Japanese
###end article-title 81
###begin article-title 82
Cloning and expression analysis of a novel member of the facilitative glucose transporter family, SLC2A9 (GLUT9)
###end article-title 82
###begin article-title 83
###xml 61 66 <span type="species:ncbi:9606">human</span>
PJA1, encoding a RING-H2 finger ubiquitin ligase, is a novel human X chromosome gene abundantly expressed in brain
###end article-title 83
###begin article-title 84
Subsystems contributing to the decline in ability to walk: bridging the gap between epidemiology and geriatric practice in the InCHIANTI study
###end article-title 84
###begin article-title 85
Age-associated declines in complex walking task performance: the Walking InCHIANTI toolkit
###end article-title 85
###begin article-title 86
Heritability of cardiovascular and personality traits in 6,148 Sardinians
###end article-title 86
###begin article-title 87
The distribution of HLA class II haplotypes reveals that the Sardinian population is genetically differentiated from the other Caucasian populations
###end article-title 87
###begin article-title 88
###xml 39 44 <span type="species:ncbi:9606">human</span>
Identification and characterization of human glucose transporter-like protein-9 (GLUT9): alternative splicing alters trafficking
###end article-title 88
###begin article-title 89
###xml 0 5 <span type="species:ncbi:10090">Mouse</span>
Mouse glucose transporter 9 splice variants are expressed in adult liver and kidney and are up-regulated in diabetes
###end article-title 89
###begin article-title 90
Serum uric acid in essential hypertension: an indicator of renal vascular involvement
###end article-title 90
###begin article-title 91
Relation of serum uric acid to mortality and ischemic heart disease. The NHANES I Epidemiologic Follow-up Study
###end article-title 91
###begin article-title 92
###xml 45 51 <span type="species:ncbi:9606">humans</span>
Uric acid provides an antioxidant defense in humans against oxidant- and radical-caused aging and cancer: a hypothesis
###end article-title 92
###begin article-title 93
Genome wide association scan shows genetic variants in the FTO gene are associated with obesity related traits
###end article-title 93
###begin article-title 94
Family based association tests for genome wide association scans
###end article-title 94
###begin article-title 95
###xml 4 9 <span type="species:ncbi:9606">human</span>
The human genome browser at UCSC
###end article-title 95
###begin article-title 96
Primer3 on the WWW for general users and for biologist programmers
###end article-title 96
###begin article-title 97
###xml 23 28 <span type="species:ncbi:9606">human</span>
A haplotype map of the human genome
###end article-title 97
###begin article-title 98
GOLD-graphical overview of linkage disequilibrium
###end article-title 98
###begin p 99
A previous version of this article appeared as an Early Online Release on September 26, 2007 (doi:).
###end p 99
###begin p 100
###xml 0 21 0 21 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Author contributions.</bold>
Author contributions. D. Schlessinger and E. Lakatta conceived and designed the experiments. S. Li, A. Maschio, F. Busonero, G. Usala, A. Mulas, S. Lai, M. Dei, M. Orru, S. Naitza, L. Crisponi, M. Uda, and R. Nagaraja performed the experiments. S. Sanna, G. Albai, G. Abecasis, L. Ferrucci, and W. Chen analyzed the data. S. Bandinelli, S. Najjar, J. Guralnik, G. Abecasis, L. Ferrucci, M. Uda, and W. M. Chen contributed reagents/materials/analysis tools. S. Sanna, D. Schlessinger, A. Scuteri, A. Cao, G. Abecasis, L. Ferrucci, and R. Nagaraja wrote the paper. D. Schlessinger was project officer for the SardiNIA project
###end p 100
###begin p 101
###xml 0 8 0 8 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Funding.</bold>
Funding. This work was supported by the Intramural Research Program of the National Institute on Aging (NIA), National Institutes of Health (NIH). The SardiNIA ("Progenia") team was supported by Contract NO1-AG-1-2109 from the NIA; the efforts of GRA, SS, and WC were supported in part by contract 263-MA-410953 from the NIA to the University of Michigan and by research grant HG02651 from the NIH (to GRA). The InCHIANTI Study was supported in part by the Italian Ministry of Health (ICS 110.1/RS97.71) and US NIA (Contracts N01-AG-916413, N01-AG-821336, 263 MD 9164 13, and 263 MD 821336)
###end p 101
###begin p 102
###xml 0 20 0 20 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Competing interests.</bold>
Competing interests. The authors have declared that no competing interests exist.
###end p 102

